Mumbai, Oct. 16 -- Ipca Laboratories has incorporated a wholly owned subsidiary by the
name "Ipca Pharmaceuticals GmbH" in the Federal Republic of Germany, with an initial paid up capital of Euro € 25,000, inter-alia, to hold product registrations, participate in the institutional and other business and undertake distribution of generic formulations in the said country.
Published by HT Digital Content Services with permission from Capital Market....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.